I-COVID 19: Izitokhwe eziphezulu ze-5 zePharma zokuTyala imali kwi-2020

Inkonzo yokurhweba ikopi. I-Algo yethu ivula ngokuzenzekelayo kwaye ivale urhwebo.

I-L2T Algo inikezela ngemiqondiso enengeniso ephezulu kunye nomngcipheko omncinci.

24/7 urhwebo cryptocurrency. Ngelixa ulalayo, siyarhweba.

Ukuseta imizuzu eli-10 kunye neenzuzo ezinkulu. Incwadi yesikhokelo ibonelelwe ngokuthenga.

79% izinga lempumelelo. Iziphumo zethu ziya kukuvuyisa.

Ukuya kuthi ga kwi-70 yorhwebo ngenyanga. Kukho ngaphezu kwe-5 izibini ezikhoyo.

Imirhumo yenyanga iqala kwi-£58.

L2T Into

IINKCUKACHA

IINKCUKACHA

Nangona ubhubhani weCorona (COVID-19) osuleleka kakhulu ubangela isiphithiphithi kwihlabathi liphela, iziphumo zaso ziye zavakala phantse kuwo onke amacandelo ehlabathi. Iifemu zeBiotech zikwindawo ebalekayo ngokuchasene nexesha elisemva kwemiboniso ukwenza isitofu sokugonya i-pathogen. Ngoku kukho abatyali-mali abaninzi abafuna ukutyala imali kule mizi-mveliso.

1. GlaxoSmithKline
Ingomnye wabenzi bogonyo abakhulu emhlabeni, le nkampani yaseBritane yebhayoloji iphambili phakathi kweefemu. Yaziwa njengovulindlela kwimveliso yesitofu sokugonya.

Isitofu sokugonya somkhuhlane wonyaka kunye nesitofu sokugonya i-Human Papillomavirus (HPV) ziphakathi kwegalelo eliphezulu kwihlabathi. Isebenzisana neClover Biopharmaceuticals, ifem yebhayoloji esekwe eTshayina.

Okwangoku, bayasebenzisana kwimveliso yesitofu sokugonya esixhomekeke kwi-COVID-19.

2. USanofi
I-Sanofi Pasteur, inkampani yaseFransi yebhayoloji, yenye yabathathi-nxaxheba abakhulu kumlo ochasene ne-coronavirus phantsi kwecandelo layo lokugonya.

Isebenzisana ne-US Biomedical Advanced Research and Development Authority (BARDA) ngokubambisana.

I-BRDA iyingxenye yeSebe lezeMpilo kunye neSebe leeNkonzo zoLuntu (HHS), elisebenza phantsi kweOfisi yoNobhala oNcedisayo wokuLungiselela nokuPhendula (ASPR).

Bonke bathathela ingqalelo isitofu sokugonya sangaphambi kweklinikhi se-SARS njengomviwa onokubakho. Umgqatswa wogonyo lwe-SARS wachongwa ngo-2017. Oku kunokunika inkampani inzuzo ngaphezu kwabo bakhuphisana nabo kuba i-SARS iyinxalenye yodidi lweCoronavirus.

3. UJohnson & Johnson
U-Janssen, isebe logonyo likaJohnson & Johnson, naye ebeyinxalenye yedabi langoku ukusukela ngoJanuwari 2020. Ukuphumelela idabi amayeza aseMelika athathe indlela emacala-mbini.

Kwelinye icala, ithala leencwadi lee-antiviral leemolekyuli lihlola ulungelelwano lwendalo lwentsholongwane entsha. Kwaye kwelinye icala, isebenza kwisitofu sokugonya kusetyenziswa isixhobo ebesiphuhliselwe ugonyo lokugonyelwa i-Ebola.

NjengoSanofi, oku kusebenza kwintsebenziswano ebanzi kunye ne-BRDA.

4. KwiSayensi zeGiliyadi
Yaziwa ngcono ngamayeza ayo okulwa i-Hepatitis C Virus (HCV), iGiliyadi ibisenza uphando ngogonyo lwe-COVID-19. Ichiza le-Remdesivir ngoku lineemvavanyo kwaye libeke inkampani phezulu kuluhlu lwecrème de la crème yeenkampani ezixuba amayeza.

Olu gonyo ekuqaleni bekufanele ukuba lunyanga intsholongwane ye-Ebola kwaye kuthiwa sele luncedise isigulana esinye se-coronavirus e-US. Umsebenzi omninzi e-China uqalile kwaye inkampani kulindeleke ukuba iqalise iimvavanyo zayo zasemva kwexesha enyangeni.

5. IRegeneron Pharmaceuticals
Rhoqo, iRegeneron isebenza ngokudibeneyo ne-BRDA ukwenza unyango lwentsholongwane. Oku kusebenzisa inkqubo esebenzayo ekuphuhliseni ichiza lentsholongwane ye-Ebola.

Oku kubandakanya ukwazisa iimpuku ezenziwe ngokwemfuza kwiiproteni ze-coronavirus ezinezixokelelwano zokhuselo lomntu. Injongo kukuba iimpuku zenze amajoni omzimba kwiiproteni. Ngexesha elifanayo, abantu abaye bazinza kwisigulo basebenzisa izilwa-buhlungu.

Bajonge ukukhetha eyona ingcono kakhulu kwezi, abaza kuyisebenzisa ukwenza umxube wokunyanga intsholongwane. Imveliso iya kuba ilungele izilingo zabantu ekuqaleni kwehlobo, inkampani ithi.

IMarike yeStock kunye neCoronavirus
Oku kusifanele isaziso sokuba iinkxalabo zobhubhani zibangele ukungaqiniseki kwemarike yemasheya. Nangona iireyithi zezinye iifemu ziye zehla kakhulu, ezininzi ziye zanda. Iifemu zokhathalelo lwempilo kunye nezamayeza ziphakathi kwezinye.

Ukuthathela ingqalelo ukuba la mashishini agxile kunyango lwentsholongwane eyosulelayo kakhulu, ilandela ngokusengqiqweni ukuba izitokhwe zabo zithwala ithuba lenzuzo enkulu. Iimveliso zabo zikwaxhamla kwizixa eziphezulu zezicelo ngaphandle kokuqhambuka.

Ke ayisiyo mfihlakalo ukuba uninzi lwesitokhwe samayeza, ngakumbi isitokhwe se-GILD, sele sikwisantya esiphezulu, sodlula i-S&P 500 nangona yaqala ukwehla ngokuzinzileyo ngoFebruwari.

Ulindelo lwesitofu se-COVID 19
Kungathatha ixesha, ubuncinci unyaka okanye ngaphezulu, ngokweengcali, ngaphambi kokuba umhlaba ekugqibeleni ufumane isitofu sokugonya i-COVID-19 eyoyikekayo.
Ngaphaya koko, ukwazisa ezo zitokhwe kuluhlu lokubukela lotyalo-mali yindlela entle yokugcina umkhondo weentshukumo zazo njengoko zifumana umhlaba ekukhuleni kwesitofu sokugonya.

Isikhokelo soTyalo-mali kwiiFirms ze-Pharma
Kubathengi base-US, nge-Stash Invest, i-stockbroker engekho-ikhomishini ethengisa i-5 ye-stocks yamayeza, unokutyala imali kwiinkampani zamachiza.

Ngaba uzinze ngaphandle kwe-USA? Sicebisa i-Plus500 ebonelela ngokusasazeka okuphantsi kutyalo-mali kwizitokhwe zamayeza kunye neqonga elilawulwa kakuhle.